SHANK1

Recent articles

Oil and water with colors behind: blue, green, yellow and red.

How microscopic ‘condensates’ in cells might contribute to autism

A controversial idea about how cells compartmentalize their contents into droplets — like beads of oil in water — could be key to understanding autism, says Julie Forman-Kay.

By Angie Voyles Askham
23 February 2021 | 7 min read
Spectrum from The Transmitter.

The treasures of monkey island

On Cayo Santiago island, scientists track the alliances and power struggles of a colony of feral monkeys — collecting data to generate new insights into the social challenges that people with autism face.

By Brendan Borrell
22 June 2016 | 23 min read
Spectrum from The Transmitter.

Neighboring mutations in gene may spawn separate conditions

Two seemingly similar mutations in the SHANK3 gene have divergent effects on the brain and behavior.

By Jessica Wright
25 January 2016 | 4 min read
Spectrum from The Transmitter.

Rodent learning sheds light on missed social cues in autism

Many people with autism have trouble interpreting and responding to social cues. Studying how rats learn from each other can provide insights into the human social brain, says Amiel Rosenkranz.

By Amiel Rosenkranz
28 July 2015 | 9 min read
Spectrum from The Transmitter.

Family of autism-linked proteins helps neurons communicate

The SHANK family of proteins, some of which are strong autism candidates, work together to facilitate brain signaling, according to unpublished results presented yesterday at the 2014 Society for Neuroscience annual meeting in Washington, D.C.

By Jessica Wright
16 November 2014 | 3 min read
Spectrum from The Transmitter.

SHANK3 mutations turn up in high proportion of autism cases

About 2 percent of people who have both autism and intellectual disability carry harmful mutations in SHANK3, a protein that helps organize the connections between neurons, according to a study published 4 September in PLoS Genetics.

By Jessica Wright
18 September 2014 | 4 min read
Spectrum from The Transmitter.

Drug fixes cellular defects in autism-related disorder

A new stem-cell model of Phelan-McDermid syndrome points to a possible treatment for the rare autism-related disorder, according to a study published in Nature.

By Virginia Hughes
2 December 2013 | 5 min read
Spectrum from The Transmitter.

Where will the focus on SHANK genes lead?

Geneticists react to discoveries and identify next steps for one of autism’s most promising candidate genes.

By Greg Boustead
11 November 2013 | 5 min read
Spectrum from The Transmitter.

SHANK mutations converge at neuronal junctions in autism

SHANK3, one of the strongest candidate genes for autism, has the potential to be a molecular entry point into understanding the synaptic, developmental and circuit origins of the disorder.  

By Meera Modi, Michael Ehlers
5 November 2013 | 6 min read
Spectrum from The Transmitter.

Risk factors

To focus the search for environmental risk factors in autism, we should look for chemicals that influence the molecular pathways associated with candidate risk genes, say Pamela Lein and Marianna Stamou.

By Pamela Lein, Marianna Stamou
26 February 2013 | 3 min read

Explore more from The Transmitter

Methodological flaw may upend network mapping tool

The lesion network mapping method, used to identify disease-specific brain networks for clinical stimulation, produces a nearly identical network map for any given condition, according to a new study.

By Angie Voyles Askham
15 January 2026 | 7 min read
Crowd seen from above.

Common and rare variants shape distinct genetic architecture of autism in African Americans

Certain gene variants may have greater weight in determining autism likelihood for some populations, a new study shows.

By Laura Dattaro
15 January 2026 | 5 min read
Research image of stem cells derived from people of African ancestry.

Bringing African ancestry into cellular neuroscience

Two independent teams in Africa are developing stem cell lines and organoids from local populations to explore neurodevelopmental and neurodegenerative conditions.

By Lauren Schenkman
14 January 2026 | 7 min read

privacy consent banner

Privacy Preference

We use cookies to provide you with the best online experience. By clicking “Accept All,” you help us understand how our site is used and enhance its performance. You can change your choice at any time. To learn more, please visit our Privacy Policy.